These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 16464217)

  • 1. Nonstimulant medications for the treatment of ADHD.
    Rains A; Scahill L; Hamrin V
    J Child Adolesc Psychiatr Nurs; 2006 Feb; 19(1):44-7. PubMed ID: 16464217
    [No Abstract]   [Full Text] [Related]  

  • 2. The safety of non-stimulant agents for the treatment of attention-deficit hyperactivity disorder.
    Himpel S; Banaschewski T; Heise CA; Rothenberger A
    Expert Opin Drug Saf; 2005 Mar; 4(2):311-21. PubMed ID: 15794722
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacological management of attention-deficit hyperactivity disorder.
    Reeves G; Schweitzer J
    Expert Opin Pharmacother; 2004 Jun; 5(6):1313-20. PubMed ID: 15163276
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of adult ADHD and comorbid disorders.
    Young JL
    CNS Spectr; 2006 Oct; 11(10 Suppl 11):10-2. PubMed ID: 17712918
    [No Abstract]   [Full Text] [Related]  

  • 5. Non-stimulant treatment of attention-deficit/hyperactivity disorder.
    Pliszka SR
    CNS Spectr; 2003 Apr; 8(4):253-8. PubMed ID: 12679740
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Advances in alternative pharmacotherapy of ADHD.
    Pityaratstian N
    J Med Assoc Thai; 2005 Sep; 88 Suppl 4():S357-62. PubMed ID: 16623055
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mechanism of action of agents used in attention-deficit/hyperactivity disorder.
    Wilens TE
    J Clin Psychiatry; 2006; 67 Suppl 8():32-8. PubMed ID: 16961428
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New developments in the treatment of ADHD.
    Biederman J; Arnsten AF; Faraone SV; Doyle AE; Spencer TJ; Wilens TE; Weiss MD; Safren SA; Culpepper L
    J Clin Psychiatry; 2006 Jan; 67(1):148-59. PubMed ID: 16426101
    [No Abstract]   [Full Text] [Related]  

  • 9. Nonstimulant medications in the treatment of attention deficit hyperactivity disorder.
    Scahill L; French PT
    J Child Adolesc Psychiatr Nurs; 1996; 9(2):39-43. PubMed ID: 8868838
    [No Abstract]   [Full Text] [Related]  

  • 10. Meta-analysis: treatment of attention-deficit/hyperactivity disorder in children with comorbid tic disorders.
    Bloch MH; Panza KE; Landeros-Weisenberger A; Leckman JF
    J Am Acad Child Adolesc Psychiatry; 2009 Sep; 48(9):884-893. PubMed ID: 19625978
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacological treatment of attention-deficit/hyperactivity disorder in adults.
    Slatkoff J; Greenfield B
    Expert Opin Investig Drugs; 2006 Jun; 15(6):649-67. PubMed ID: 16732717
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel treatments for attention-deficit/hyperactivity disorder in children.
    Spencer TJ; Biederman J; Wilens TE; Faraone SV
    J Clin Psychiatry; 2002; 63 Suppl 12():16-22. PubMed ID: 12562057
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Non-stimulant medications in the treatment of ADHD.
    Banaschewski T; Roessner V; Dittmann RW; Santosh PJ; Rothenberger A
    Eur Child Adolesc Psychiatry; 2004; 13 Suppl 1():I102-16. PubMed ID: 15322961
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evidence-based pharmacotherapy for attention-deficit hyperactivity disorder.
    Biederman J; Spencer T; Wilens T
    Int J Neuropsychopharmacol; 2004 Mar; 7(1):77-97. PubMed ID: 14733627
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tricyclic antidepressants (TCA) may improve atomoxetine's efficacy.
    Niederhofer H
    Int J Neuropsychopharmacol; 2008 Sep; 11(6):877. PubMed ID: 18346294
    [No Abstract]   [Full Text] [Related]  

  • 16. Decreased use of clonidine following treatment with atomoxetine in children with ADHD.
    Johnston JA; Ye W; Van Brunt DL; Pohl G; Sumner CR
    J Clin Psychopharmacol; 2006 Aug; 26(4):389-95. PubMed ID: 16855457
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nonstimulant therapies for attention-deficit hyperactivity disorder (ADHD) in children and adults.
    Waxmonsky JG
    Essent Psychopharmacol; 2005; 6(5):262-76. PubMed ID: 16222911
    [TBL] [Abstract][Full Text] [Related]  

  • 18. alpha2-Adrenergic receptor agonists for the treatment of attention-deficit/hyperactivity disorder: emerging concepts from new data.
    Arnsten AF; Scahill L; Findling RL
    J Child Adolesc Psychopharmacol; 2007 Aug; 17(4):393-406. PubMed ID: 17822336
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacologic alternatives to psychostimulants for the treatment of attention-deficit/hyperactivity disorder.
    Popper CW
    Child Adolesc Psychiatr Clin N Am; 2000 Jul; 9(3):605-46, viii. PubMed ID: 10944659
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tic exacerbation and precipitation during atomoxetine treatment in two children with attention-deficit hyperactivity disorder.
    Párraga HC; Párraga MI; Harris DK
    Int J Psychiatry Med; 2007; 37(4):415-24. PubMed ID: 18441629
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.